As described above, the inactivation of ELF3 increased the rate of cell death and decreased FOXM1 levels in NSCLC with K-Ras and EGFR T790M/L858R mutations in vitro and in vivo. The gene discussed is FOXM1; the disease is non-small cell lung carcinoma.